[Federal Register: September 3, 1998 (Volume 63, Number 171)]
[Notices]               
[Page 47041]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03se98-99]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated January 21, 1998, and published in the Federal 
Register on February 12, 1998, (63 FR 7182), Roche Diagnostic Systems, 
Inc., 1080 U.S. Highway 202, Somerville, New Jersey 08876-3771, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of ecgonine (9180), a basic class 
of controlled substance listed in Schedule II.
    The firm plans to manufacture small quantities of ecgonine which 
will be further converted into derivatives for incorporation in drug of 
abuse detection kits.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Roche Diagnostic 
Systems, Inc. to manufacture ecgonine is consistent with the public 
interest at this time. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 
0.100 and 0.104, the Deputy Assistant Administrator, Office of 
Diversion Control, hereby orders that the application submitted by the 
above firm for registration as a bulk manufacturer of the basic class 
of controlled substance listed above is granted.

    Dated: June 23, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-23691 Filed 9-2-98; 8:45 am]
BILLING CODE 4410-09-M